StockData
PLURNasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends June 30

Pluri Inc.

Financials through Q4 FY2026, quarter ended Jun 30, 2026Last filing: 10-K on Sep 10, 2026
$0.85−0.08 (-8.58%)

Close on Oct 19, 2026

Market cap
$9.08M
P/E (TTM)
–
Dividend yield
–

Earnings

Quarterly results announced on Form 8-K, Item 2.02

No earnings releases found

Pluri has not filed an earnings release (Form 8-K, Item 2.02) that we could match to a fiscal quarter.

Press releases

Announcements Pluri filed with the SEC